| Record ID | marc_columbia/Columbia-extract-20221130-007.mrc:432514385:3687 |
| Source | marc_columbia |
| Download Link | /show-records/marc_columbia/Columbia-extract-20221130-007.mrc:432514385:3687?format=raw |
LEADER: 03687mam a22003974a 4500
001 3424595
005 20221020071758.0
008 021003t20032003dcuaf b 101 0 eng
010 $a 2002035645
020 $a0841237808 (alk. paper)
035 $a(OCoLC)ocm50773579
035 $9AVP5308CU
035 $a(NNC)3424595
035 $a3424595
040 $aDLC$cDLC$dC#P$dAGL$dOrLoB-B
042 $apcc
050 00 $aQP603.I5$bI566 2003
070 0 $aQD1$b.A45 no. 839
072 0 $aX300
082 00 $a615/.7$221
245 00 $aInosine monophosphate dehydrogenase :$ba major therapeutic target /$cKrzysztof W. Pankiewicz, editor, Barry M. Goldstein, editor.
260 $aWashington, DC :$bAmerican Chemical Society :$bDistributed by Oxford University Press,$c[2003], ©2003.
300 $axiv, 352 pages, 8 unnumbered pages of plates :$billustrations (some color) ;$c24 cm.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
490 1 $aACS symposium series ;$v839
504 $aIncludes bibliographical references and indexes.
505 00 $g1.$tInosine Monophosphate Dehydrogenase and Its Inhibitors: An Overview /$rKrzysztof W. Pankiewicz and Barry M. Goldstein -- $g2.$tIMP, DH, and GTP: Linkage with Neoplasia, Target of Chemotherapy, Regulation of Ras, Signal Transduction, and Apoptosis /$rGeorge Weber -- $g3.$tBiological Significance of Guanylate Synthesis and IMP Dehydrogenase Isoforms /$rYutaka Natsumeda -- $g4.$tAn Emerging Cell Kinetics Regulation Network: Integrated Control of Nucleotide Metabolism and Cancer Gene Function /$rJames L. Sherley -- $g5.$tTargeted Disruption of the IMPDH: Type II Gene: Effect on Mouse Development and Lymphocyte Activation /$rJing Jin Gu, Sander Stegmann and Beverly S. Mitchell -- $g6.$tDifferential Splicing of Pneumocystis carinii Inosine 5'-Monophosphate Dehydrogenase mRNA: Implications for Producing Catalytically Active Protein /$rDongjiu Ye, Jeniece Nott and Sherry F. Queener -- $g7.$tIMPDH Structure and Ligand Binding /$rBarry M. Goldstein, Dipesh Risal and Michael Strickler --
505 80 $g8.$tMonovalent Cation Activation of IMP Dehydrogenase /$rGeorge D. Markham -- $g9.$tIMP Dehydrogenase: Mechanism of Drug Selectivity /$rLizbeth Hedstrom and Jennifer A. Digits -- $g10.$tThe Discovery of Thiazole-4-Carboxamide Adenine Dinucleotide (TAD) and a Recent Synthetic Approach for the Construction of a Hydrolytically Resistant Surrogate /$rVictor E. Marquez -- $g11.$tC-Nucleoside Analogs of Tiazofurin and Selenazofurin as Inosine 5'-Monophosphate Dehydrogenase Inhibitors /$rP. Franchetti, L. Cappellacci, M. Grifantini, H. N. Jayaram and B. M. Goldstein -- $g12.$tStudies with Benzamide Riboside, a Recent Inhibitor of Inosine 5'-Monophosphate Dehydrogenase /$rHiremagalur N. Jayaram, Joel A. Yalowitz, Georg Krupitza, Thomas Szekeres, Karsten Krohn and Krzysztof W. Pankiewicz -- $g13.$tCofactor Analogues as Inhibitors of IMP Dehydrogenase: Design and New Synthetic Approaches /$rKrzysztof W. Pankiewicz, Steven Patterson, Hiremagalur N. Jayaram and Barry M. Goldstein --
505 80 $g14.$tIdentification of Specific Inhibitors of IMP Dehydrogenase /$rFrank R. Collart and Eliezer Huberman -- $g15.$tMizoribine: Experimental and Clinical Experience /$rHiroaki Ishikawa, Masahiko Tsuchiya and Hiromichi Itoh.
650 0 $aIMP dehydrogenase$vCongresses.
650 0 $aIMP dehydrogenase$xInhibitors$vCongresses.
700 1 $aPankiewicz, Krzysztof W.,$d1942-$0http://id.loc.gov/authorities/names/n2002161449
700 1 $aGoldstein, Barry M.,$d1952-$0http://id.loc.gov/authorities/names/n2002162550
830 0 $aACS symposium series ;$v839.
852 00 $boff,che$hQP603.I5$iI566 2003